[1]
K. Y. Peleshok, “QUALITY CONTROL MEASUREMENT AND IN VITRO BIOEQUIVALENCE OF VALSARTAN AND ATENOLOL TABLETS MARKETED IN UKRAINE”, IJMMR, vol. 6, no. 2, pp. 52–58, May 2021.